Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Giunchi F, Jordahl K, Bollito E, Colecchia M, Patriarca C, D'Errico A, et al. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer. Virchows Arch. 2017;470(6):711-715.

DeSimone RA, Schwartz J, Schneiderman J. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations. J Clin Apher. 2017;32(6):543-552.

Muddana V, Goyal A, Chahal P. Endoscopic ultrasound-guided fine needle aspiration and diagnosis of omental plasmacytoma. Endosc Ultrasound. 2017;6(4):278-279.

Fei T, Chen Y, Xiao T, Li W, Cato L, Zhang P, et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proc Natl Acad Sci U S A. 2017;114(26):E5207-E5215.

Alkadi MM, Kim J, Aull MJ, Schwartz JE, Lee JR, Watkins A, et al. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study. Clin Transplant. 2017;31(11).

Nottegar A, Tabbo F, Luchini C, Guerrera F, Gaudiano M, Bria E, et al. Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis. Exp Mol Pathol. 2017;102(2):276-279.

Gao J, Perlman A, Kalache S, Berman N, Seshan S, Salvatore S, et al. Multiparametric Quantitative Ultrasound Imaging in Assessment of Chronic Kidney Disease. J Ultrasound Med. 2017;36(11):2245-2256.

Wilkes DC, Sailer V, Xue H, Cheng H, Collins CC, Gleave M, et al. A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents. Cold Spring Harb Mol Case Stud. 2017;3(5).

Sailer V, Pauli C, Merzier EC, Mosquera JM, Beltran H, Rubin MA, et al. On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study. Anticancer Res. 2017;37(4):1569-1573.

Sinnott JA, Peisch SF, Tyekucheva S, Gerke T, Lis R, Rider JR, et al. Prognostic Utility of a New mRNA Expression Signature of Gleason Score. Clin Cancer Res. 2017;23(1):81-87.